Boston Scientific Corp Stock Performance
| BSX Stock | USD 90.75 0.54 0.60% |
Boston Scientific has a performance score of 14 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boston Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boston Scientific is expected to be smaller as well. Boston Scientific Corp right now shows a risk of 0.98%. Please confirm Boston Scientific Corp value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Boston Scientific Corp will be following its price patterns.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Actual Historical Performance (%)
One Day Return 0.6 | Five Day Return (1.13) | Year To Date Return 56.9 | Ten Year Return 604.03 | All Time Return 2 K |
Last Split Factor 2:1 | Last Split Date 2003-11-06 |
1 | Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | 09/13/2024 |
2 | ResMed Inc. Hits Fresh High Is There Still Room to Run | 10/28/2024 |
3 | Boston Scientific CEO sells shares worth 13.8 million | 11/07/2024 |
4 | Sumitomo Mitsui Trust Group Inc. Acquires 30,636 Shares of Boston Scientific Co. | 11/12/2024 |
5 | Baseless fears about flouride are going mainstream | 11/13/2024 |
6 | Boston Scientific Co. Shares Sold by MAI Capital Management | 11/19/2024 |
7 | Disposition of 4877 shares by Edward Ludwig of Boston Scientific at 91.6346 subject to Rule 16b-3 | 11/21/2024 |
8 | Why Is Boston Scientific Up 7.5 percent Since Last Earnings Report | 11/22/2024 |
9 | Disposition of 14010 shares by Arthur Butcher of Boston Scientific at 89.2694 subject to Rule 16b-3 | 11/25/2024 |
10 | Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 | 11/26/2024 |
| Begin Period Cash Flow | 1.1 B |
Boston |
Boston Scientific Relative Risk vs. Return Landscape
If you would invest 8,114 in Boston Scientific Corp on August 31, 2024 and sell it today you would earn a total of 961.00 from holding Boston Scientific Corp or generate 11.84% return on investment over 90 days. Boston Scientific Corp is generating 0.1826% of daily returns assuming volatility of 0.9842% on return distribution over 90 days investment horizon. In other words, 8% of stocks are less volatile than Boston, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Boston Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boston Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Boston Scientific Corp, and traders can use it to determine the average amount a Boston Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1855
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BSX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.98 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Boston Scientific is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Boston Scientific by adding it to a well-diversified portfolio.
Boston Scientific Fundamentals Growth
Boston Stock prices reflect investors' perceptions of the future prospects and financial health of Boston Scientific, and Boston Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boston Stock performance.
| Return On Equity | 0.0892 | ||||
| Return On Asset | 0.049 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 142.51 B | ||||
| Shares Outstanding | 1.47 B | ||||
| Price To Earning | 107.05 X | ||||
| Price To Book | 6.46 X | ||||
| Price To Sales | 8.41 X | ||||
| Revenue | 14.24 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.45 B | ||||
| Net Income | 1.59 B | ||||
| Cash And Equivalents | 928 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 9.49 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | 14.05 X | ||||
| Cash Flow From Operations | 2.5 B | ||||
| Earnings Per Share | 1.21 X | ||||
| Market Capitalization | 133.75 B | ||||
| Total Asset | 35.14 B | ||||
| Retained Earnings | 819 M | ||||
| Working Capital | 1.58 B | ||||
| Current Asset | 1.21 B | ||||
| Current Liabilities | 923 M | ||||
About Boston Scientific Performance
Evaluating Boston Scientific's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Boston Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Boston Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 208.67 | 167.64 | |
| Return On Tangible Assets | 0.11 | 0.11 | |
| Return On Capital Employed | 0.08 | 0.14 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.08 | 0.06 |
Things to note about Boston Scientific Corp performance evaluation
Checking the ongoing alerts about Boston Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boston Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Boston Scientific is unlikely to experience financial distress in the next 2 years | |
| Boston Scientific has a very strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 |
- Analyzing Boston Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boston Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Boston Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boston Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boston Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boston Scientific's stock. These opinions can provide insight into Boston Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.